today were also active in the past and suggest that these three inflection points correspond to the three predicted in models (2, 4) (Fig. 4) ; if so, then the NPLD accumulated primarily in four climatologically distinct stages. More work is required to determine whether the lower unconformities match the predicted ages, as in the case of the WRAP, but we present them again here and revise the accumulation scenario posited by (16).
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ORGANIC CHEMISTRY
Enantioselective synthesis of an ophiobolin sesterterpene via a programmed radical cascade Zachary G. Brill, Huck K. Grover, Thomas J. Maimone* Cyclase enzymes weave simple polyprenyl chains into the elaborate polycyclic ring systems of terpenes, a sequence that is often difficult to emulate under abiotic conditions. Here we report a disparate synthetic approach to complex terpenes whereby simple prenyl-derived chains are cyclized using radical, rather than cationic, reaction pathways. This strategy allowed us to efficiently forge the intricate 5-8-5 fused ring systems found in numerous complex natural product classes and also enabled a nine-step total synthesis of (-)-6-epi-ophiobolin N, a member of the large family of cytotoxic ophiobolin sesterterpenes. A small-molecule thiol catalyst was found to override the inherent diastereoselectivity observed during a reductive radical cascade cyclization process. This work lays the foundation for efficient synthesis of terpenoid ring systems of interest in medicinal research, particularly those that have been historically challenging to access.
T erpenes represent a highly diverse class of natural products whose derivatives have been developed into numerous medications approved by the U.S. Food and Drug Administration for the treatment of cancer, bacterial infection, malaria, and various other human diseases (1, 2) . Despite these successes, terpenes can pose distinct challenges for medicinal research because of their often-limited commercial availability, resistance to deep-seated structural modifications, and incompletely elucidated biosynthetic pathways. Owing to their nonmodular chemical structures, a unifying strategy for the chemical synthesis of terpenes does not exist, further exacerbating the difficulties of working with these compounds (3) . Terpenes arise via the enzymatic conversion of simple polyprenyl chains into highly intricate polycyclic carbon networks of extraordinary diversity (4) . Biomimetic synthesis, the act of emulating nature's bond construction process, would be an ideal synthetic tool in this context (5, 6) . Indeed, cationic polyene cyclizations are perhaps the best studied of all biomimetic cyclization reactions (7). To date, however, a very limited subset of terpenoid carbocyclic diversity can be accessed in this manner in a laboratory setting, and the synthesis of many medium and larger terpene ring frameworks has proven especially problematic. In contrast, shaperestricted enzyme cavities in terpene cyclases have evolved with appropriately placed amino acid residues to stabilize selective transition states and, in concert, dictate cyclization pathways. As a result of modulating this environment, the formation of myriad terpene skeletons, elaborate rearrangement processes, and various termination modes all become chemically possible (4). Here we describe a disparate approach, in which simple polyprenyl-derived chains are cyclized via radical-based (as opposed to cationic-based) methods. Through the use of different reagent combinations, we show that the termination modes of these cyclizations can be controlled and, with a chiral small-molecule thiol catalyst, their inherent stereochemical preferences altered.
Complex 5-8-n fused ring systems (n = 5 or 6) are found in numerous di-and sesterterpenes that possess notable antibiotic (8) , cytotoxic (9) , and immunosuppressant properties, among others (10) (Fig. 1 ). Central to this structural type is the continually expanding family of ophiobolin sesterterpenes featuring a stereochemically rich and synthetically formidable 5-8-5 fused ring system (Fig. 1A) . Though compounds in this family were initially investigated for their phytotoxic effects, which negatively influence agricultural production, ophiobolin A (1) was later discovered to be a powerful inhibitor of calmodulin and remains an important tool for studying this calcium signaling protein (11) . Most recently, these fungal metabolites have attracted much attention for their potent cytotoxic effects against multiple cancer cell lines, including the highly drugresistant human brain tumor glioblastoma multiforme (12) (13) (14) . Although more than 30 distinct members have been identified to date, often in minute and varying quantities, ophiobolin A (1), ophiobolin C (2), and 6-epi-ophiobolin N (3) highlight the major structural variations found in this terpenoid family, including (i) hydroxylation at carbon-3 or dehydration to an enone system; (ii) epimeric stereochemistry at carbon-6 for nearly all members; and (iii) myriad side-chain oxidation motifs, sometimes resulting in tetrahydrofuran (THF) ring formation (see 1, for example) (11, 15) . Notwithstanding decades of research by numerous laboratories (16) (17) (18) (19) (20) (21) (22) , only Rowley et al. (23) and, more recently, Tsuna et al. (24) have charted fully synthetic routes to various ophiobolin members. Despite these achievements, the long step counts required (38 steps to 2, 47 steps to 1, respectively) are limitations for accessing numerous family members, conducting in-depth structure activity studies, and ultimately producing superior derivatives. Undoubtedly, these limitations are a direct consequence of the challenges posed by the carbogenic complexity of the ophiobolins.
In analyzing previous syntheses of ophiobolins, the lengthy, stepwise construction of the 5-8-5 fused ring system stands in marked contrast to the concise cyclase-mediated biosynthetic pathway ( Fig. 2A) . Chiba et al. proposed that the biosynthesis of the ophiobolins involves a cationic cyclization of geranylfarnesyl pyrophosphate to carbocation 4, which-through a hydride shift, transannular cyclization, and hydration processis then converted into the 5-8-5 fused skeleton of 5 (the process is shown in one step for simplicity) (25) . In developing a retrosynthesis of ophiobolins, we were inspired by hypothetical carbon-centered radical 6 and considered its formation by the 8-endo/5-exo-cascade cyclization process shown (see 7→6, Fig. 2B ). Further disconnection, via the illustrated hypothetical four-component coupling sequence, led to the identification of linalool (C-10) and farnesol (C-15) as suitable materials wherein the carbons labeled in red are incorporated into the final target. Thus, the central tenet of our synthetic strategy was a desire to use the biochemical building blocks but to forge the bonds in an abiotic fashion-a strategy that we have previously found to facilitate the synthesis of simpler terpenoids (26) .
Seeking to realize aspects of this synthetic blueprint, we prepared cyclopentenone 9 via a short sequence from the abundant monoterpene (-)-linalool (Fig. 3) . A solvent-free ring closing metathesis reaction catalyzed by 0.1 mole percent (mol %) of the Hoveyda-Grubbs second-generation catalyst (HG-II) was first used to construct the cyclopentene ring (27) , and upon complete consumption of linalool, the reaction mixture was diluted with THF and silylated in situ [NaH, tertbutyldimethylsilyl chloride (TBSCl)], affording chiral cyclopentene 8 in near-quantitative yield (>95%). After examining a variety of allylic oxidation conditions, we found that modifications to a ruthenium-catalyzed procedure developed by Miller et al. (28) smoothly furnished 9 in reasonable yield and on a multigram scale (57% isolated). In a separate vessel, we used Charette's asymmetric cyclopropanation methodology (29) in conjunction with a modified Appel procedure to prepare highly sensitive alkyl iodide 10 from geraniol. With two-step access to chiral fragments 9 and 10, we developed and optimized a challenging three-component coupling reaction, bearing strong analogy to our retrosynthetic blueprint (Fig. 2B ) but with the methylene (:CH 2 ) unit already incorporated. Treating 10 with tertbutyllithium induced lithium-halogen exchange and subsequent anionic cyclopropane fragmentation (30) . After transmetallation with a copper iodide dimethylsulfide complex, an intermediate organocopper species (12) was formed, which cleanly added to cyclopentenone 9. This 1,4-addition occurred in a diastereoselective fashion [diastereomeric ratio (dr) = 3:1], with the nucleophile approaching opposite the bulky OTBS group. After quenching with trichloroacetyl chloride, cyclopentenone 13 could be isolated via column chromatography. Even though this reaction proved sensitive to temperature and mixing efficiency, it was highly reproducible on half-gram scales.
Our efforts to effect the key radical cyclization of trichloroketone 13 were initially focused on copper-mediated atom-transfer radical cyclization processes to construct the 5-8-5 fused ring system. Though molecular models gave credence to the feasibility of this cascade process, both 8-endo and 7-exo cyclization pathways have been observed previously (31, 32) . Therefore, the outcome of this transformation, especially with RESEARCH | REPORTS regard to stereochemistry, was by no means certain (33) . However, when 13 was heated with copper(I) chloride and bipyridine, polycycle 14, which contains the desired trans 5-8 ring junction, was formed in 43% yield. The stereochemistry of this cascade, as well as of prior steps, was confirmed by x-ray crystallographic analysis of the sodium borohydride reduction product 15. If a tertiary chloride intermediate is formed under these cyclization conditions, it eliminates selectively to the tetrasubstituted olefin isomer-a process we envision to be crucial in efforts to synthesize periconicin and cotylenin A, which possess internal alkenes in this sector (Fig. 1B) . With respect to the ophiobolin synthetic problem, this termination mode is not ideal, as a key stereocenter on the newly forged cyclopentane ring is lost. After surveying a variety of options, we perceived two notable solutions. First, we found that through selective reduction of 13 [diisobutylaluminum hydride (DIBAL)/n-BuLi], the keto alcohol that subsequently formed could be converted into 16 via an Ir-catalyzed photoredox cyclization (34) . Under these cyclization conditions, the exocyclic alkene product predominates (57%), and the tetrasubstituted alkene isomer is minimized (15%). This experiment also confirmed that the key cyclopentane stereocenter was correctly set during the cyclization cascade (dr = 3:1, see supplementary materials). A small amount of reductive cyclization product 17 (10%) was also formed under these conditions. Given that a reductive process could potentially construct the basic ophiobolin side chain in its correct oxidation state directly, we optimized this transformation. By employing polarity-reversal conditions (35) involving tris(trimethylsilyl)silane and a thiol additive [3, PhSH (Ph, phenyl) was found to be optimal], reductive cyclization product 17 could be formed in good yield (74%). Triethylborane/air-mediated initiation was found to be crucial, as the temperatures needed to cajole azobisisobutyronitrile-mediated processes resulted in lower diastereoselectivity at the isopropyl-containing stereocenter (dr~1:1, temperature T = 90°C). Overall, these three cyclization modes offer rapid (four or five steps) synthetic entry into complex 5-8-5 fused tricycles with requisite handles to be converted into diverse terpenoid structures.
In an attempt to translate these results into the synthesis of full ophiobolin natural products, we subjected farnesol to an analogous four-step sequence previously described for geraniol (Fig. 4) . After the final hydride reduction step, either free alcohol 18 or its acetylated variant 19 could be isolated in one pot. Subjecting 18 to the previously discovered conditions for reductive radical cyclization afforded tricycle 20 featuring the complete eastern sector of all minimally oxidized ophiobolins. Although we were pleased to find that the diastereoselectivity at the cyclopentane stereocenter (C-14) was slightly improved relative to the geraniol-based system (dr~4:1, T = 5°C), our excitement was quickly diminished when we determined that the major product of the cascade possessed the incorrect stereochemistry at the neighboring C-15 methyl stereocenter. In particular, when using previously employed 3,5-CF 3 PhSH as a catalyst (25 mol %), we obtained a 1.6:1 mixture favoring 15-epi 20 (Fig. 4B) . Given that the thiol is believed to donate the final hydrogen atom under these conditions (35), we examined the effect of thiol structure on the diastereoselectivity of the process 18→20 (Fig.  4B ). All achiral aromatic and aliphatic thiols tested favored the incorrect isomer with slightly varying preferences (1.4:1 to 1.6:1 dr in favor of 15-epi 20) . Taking inspiration from Cai et al.'s work on enantioselective radical hydrosilylation (36), we began to examine the potential of chiral thiol catalysts to override the inherent substrate bias of this terminating hydrogen atom abstraction event (37) . Although known glucose-based thiol 24 and 1,1'-bi-2-naphthol dithiol 25 led 
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to slight improvements, we found that when employing a,a,a',a'-tetraaryl-2,2-disubstituted 1,3-dioxolane-4,5-dimethanol (TADDOL)-based monothiols 26 and 27 (derived from L-tartrate), the desired isomer was favored substantially (dr = 1.5:1 and 2.1:1, respectively). Surprisingly, the opposite enantiomer of thiol 27 (i.e., 28) was even better in this regard, resulting in a 2.9:1 diastereomeric ratio at C-15, favoring 20. The benzothiophene-based TADDOL monothiol 29 proved optimal, resulting in a 3.1:1 dr in favor of 20. Optimization of the reaction conditions and use of acetate substrate 19 afforded a 56% combined yield of reductively cyclized material favoring 21 (Fig. 4A) . The diastereoselectivity at the cyclopentane stereocenter (C-14) was further increased to >5:1 by conducting the transformation at -10°C in cyclopentane solvent. It was not possible to chromatographically separate the individual isomers of 21 at this stage, and the reported diastereomeric ratios were determined after synthetic step h in Fig. 4 (also see supplementary materials) .
Tricycle 21, accessible in only five steps from readily abundant farnesol, requires only one carbon to complete the full C-25 skeleton of the target. This task was readily accomplished via the Corey-Chaykovsky epoxidation reaction (38) , which fortuitously also removed the acetate group in the process (Fig. 4A) . A second reductive cascade process was then designed to convert this spiro-epoxide intermediate (not shown) into the requisite ophiobolin cyclooctene ring system. Thus, treatment with excess lithium naphthalenide induced reductive ring opening of the epoxide (39), with concomitant dehalogenation of the remaining chloride, presumably forming trianionic intermediate 22. Following aqueous work-up, diol 23 could be isolated in excellent yield (77%). The extraneous chlorine atoms, which are required for efficient atom transfer cyclization, are seamlessly converted into the requisite olefinic functionality found in the final target, with minimal chemical expenditure-a task that may find use in other settings. Finally, double Swern oxidation of diol 23, followed by treatment with paratoluenesulfonic acid under slightly elevated temperatures, forged (-)-6-epi-ophiobolin N (3), thus completing a nine-step enantioselective total synthesis in 2% overall yield. To date, we have used this sequence to prepare 15 mg of (-)-3.
The described synthesis of 6-epi-ophiobolin N (3) lays the foundation for the efficient synthesis of other complex 5-8-n fused terpenes for which no simple chemical or synthetic biological solutions exist. Moreover, this work also represents one of the shortest total syntheses of any known sesterterpene natural product (40) . In addition, this strategy represents a departure from biomimetic, cationic cascade processes in that the chiral reagent exerts its influence during the termination of the cascade, rather than its initiation (7); combinations of both may prove even more powerful. Nevertheless, the synthesis described here is not without flaw: a lack of complete diastereocontrol is noted in several steps. Finally, myriad reductive radical cyclizations terminate 
with a hydrogen atom abstraction step that creates a stereogenic carbon center (41 Atom transfer radical polymerization (ATRP) has become one of the most implemented methods for polymer synthesis, owing to impressive control over polymer composition and associated properties. However, contamination of the polymer by the metal catalyst remains a major limitation. Organic ATRP photoredox catalysts have been sought to address this difficult challenge but have not achieved the precision performance of metal catalysts. Here, we introduce diaryl dihydrophenazines, identified through computationally directed discovery, as a class of strongly reducing photoredox catalysts. These catalysts achieve high initiator efficiencies through activation by visible light to synthesize polymers with tunable molecular weights and low dispersities.
O ver the past two decades, atom transfer radical polymerization (ATRP) (1-4) has matured into one of the most powerful methodologies for precision polymer synthesis (5) . Strict control over the equilibrium between a dormant alkyl halide and an active propagating radical dictates a low concentration of radicals and minimizes bimolecular termination to achieve controlled polymer chain growth (6) . ATRP has historically relied on transition-metal catalysts to mediate this equilibrium and polymerize monomers with diverse functionality into macromolecules with controlled molecular weight (MW), low MW dispersity (Ð), defined chemical composition, and complex architecture (7) .
The caveat of traditional ATRP has been that the transition-metal catalysts present purification challenges for the polymer products and impede their use in biomedical and electronic applications (8) . Despite substantial strides in lowering catalyst loading (9, 10) and facilitating purification (11), organocatalyzed methods remain highly desirable for circumventing the need for metal removal, reducing toxicity concerns, and avoiding interference with electronic systems. Organocatalyzed variants of ATRP by use of alkyl iodide initiators have been established, although they are not a broadly applicable replacement for metal-catalyzed ATRP (12) (13) (14) .
Our interest in this field originated in 2013 with the discovery that perylene could serve as an organic visible-light photoredox catalyst (PC) to mediate an ATRP mechanism with alkyl bromide initiators, albeit with less control over the polymerization than has become the benchmark for traditional metal-catalyzed ATRP (15) (16) (17) . Our ongoing work has striven to establish organocatalyzed ATRP (O-ATRP) for the synthesis of polymers with the precision of traditional ATRP, using visible-light PCs to realize energy-efficient polymerization methods that eliminate a major limitation of ATRP. Although photoredox catalysis has been established for decades, visible-light photoredox catalysis has drawn increasing attention by presenting the opportunity to harness solar energy to mediate chemical transformations under mild conditions (18, 19) . Phenyl phenothiazine derivatives have since also proven effective as PCs for the ATRP of methacrylates (20) and acrylonitrile (21) but require irradiation by ultraviolet light and leave much room for improvement for generating polymers with higher molecular weights and lower dispersities coupled with increased initiator efficiency.
Our proposed mechanism of photoredox O-ATRP posits reversible electron transfer (ET) from
